127 related articles for article (PubMed ID: 37994193)
21. The role of cytochrome P450 BM3 phenylalanine-87 and threonine-268 in binding organic hydroperoxides.
Roberts AG; Katayama J; Kaspera R; Ledwitch KV; Le Trong I; Stenkamp RE; Thompson JA; Totah RA
Biochim Biophys Acta; 2016 Apr; 1860(4):669-77. PubMed ID: 26723172
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the interactions of cytochrome b5 with flavocytochrome P450 BM3 and its domains.
Noble MA; Girvan HM; Smith SJ; Smith WE; Murataliev M; Guzov VM; Feyereisen R; Munro AW
Drug Metab Rev; 2007; 39(2-3):599-617. PubMed ID: 17786641
[TBL] [Abstract][Full Text] [Related]
23. Optimisation of Cytochrome P450 BM3 Assisted by Consensus-Guided Evolution.
Vincent T; Gaillet B; Garnier A
Appl Biochem Biotechnol; 2021 Sep; 193(9):2893-2914. PubMed ID: 33860879
[TBL] [Abstract][Full Text] [Related]
24. Novel haem co-ordination variants of flavocytochrome P450BM3.
Girvan HM; Toogood HS; Littleford RE; Seward HE; Smith WE; Ekanem IS; Leys D; Cheesman MR; Munro AW
Biochem J; 2009 Jan; 417(1):65-76. PubMed ID: 18721129
[TBL] [Abstract][Full Text] [Related]
25. An efficient light-driven P450 BM3 biocatalyst.
Tran NH; Nguyen D; Dwaraknath S; Mahadevan S; Chavez G; Nguyen A; Dao T; Mullen S; Nguyen TA; Cheruzel LE
J Am Chem Soc; 2013 Oct; 135(39):14484-7. PubMed ID: 24040992
[TBL] [Abstract][Full Text] [Related]
26. Oleic acid based experimental evolution of Bacillus megaterium yielding an enhanced P450 BM3 variant.
Vincent T; Gaillet B; Garnier A
BMC Biotechnol; 2022 Jul; 22(1):20. PubMed ID: 35831844
[TBL] [Abstract][Full Text] [Related]
27. [Electrochemical measurement of intraprorein and interprotein electron transfer].
Shumiantseva VV; Bulko TV; Lisitsina VB; Urlakher VB; Kuzikov AB; Suprun EV; Archakov AI
Biofizika; 2013; 58(3):453-60. PubMed ID: 24159813
[TBL] [Abstract][Full Text] [Related]
28. A tailor-made, self-sufficient and recyclable monooxygenase catalyst based on coimmobilized cytochrome P450 BM3 and glucose dehydrogenase.
Valikhani D; Bolivar JM; Dennig A; Nidetzky B
Biotechnol Bioeng; 2018 Oct; 115(10):2416-2425. PubMed ID: 30036448
[TBL] [Abstract][Full Text] [Related]
29. Crystals in Minutes: Instant On-Site Microcrystallisation of Various Flavours of the CYP102A1 (P450BM3) Haem Domain.
Stanfield JK; Omura K; Matsumoto A; Kasai C; Sugimoto H; Shiro Y; Watanabe Y; Shoji O
Angew Chem Int Ed Engl; 2020 May; 59(19):7611-7618. PubMed ID: 32157795
[TBL] [Abstract][Full Text] [Related]
30. Flavocytochrome P450 BM3 mutant W1046A is a NADH-dependent fatty acid hydroxylase: implications for the mechanism of electron transfer in the P450 BM3 dimer.
Girvan HM; Dunford AJ; Neeli R; Ekanem IS; Waltham TN; Joyce MG; Leys D; Curtis RA; Williams P; Fisher K; Voice MW; Munro AW
Arch Biochem Biophys; 2011 Mar; 507(1):75-85. PubMed ID: 20868649
[TBL] [Abstract][Full Text] [Related]
31. Control of the stereo-selectivity of styrene epoxidation by cytochrome P450 BM3 using structure-based mutagenesis.
Huang WC; Cullis PM; Raven EL; Roberts GC
Metallomics; 2011 Apr; 3(4):410-6. PubMed ID: 21240430
[TBL] [Abstract][Full Text] [Related]
32. P450
Beyer N; Kulig JK; Bartsch A; Hayes MA; Janssen DB; Fraaije MW
Appl Microbiol Biotechnol; 2017 Mar; 101(6):2319-2331. PubMed ID: 27900443
[TBL] [Abstract][Full Text] [Related]
33. Influence of inter-domain dynamics and surrounding environment flexibility on the direct electrochemistry and electrocatalysis of self-sufficient cytochrome P450 3A4-BMR chimeras.
Castrignanò S; Di Nardo G; Sadeghi SJ; Gilardi G
J Inorg Biochem; 2018 Nov; 188():9-17. PubMed ID: 30098472
[TBL] [Abstract][Full Text] [Related]
34. Insights into an efficient light-driven hybrid P450 BM3 enzyme from crystallographic, spectroscopic and biochemical studies.
Spradlin J; Lee D; Mahadevan S; Mahomed M; Tang L; Lam Q; Colbert A; Shafaat OS; Goodin D; Kloos M; Kato M; Cheruzel LE
Biochim Biophys Acta; 2016 Dec; 1864(12):1732-1738. PubMed ID: 27639964
[TBL] [Abstract][Full Text] [Related]
35. P450(BM3) (CYP102A1): connecting the dots.
Whitehouse CJ; Bell SG; Wong LL
Chem Soc Rev; 2012 Feb; 41(3):1218-60. PubMed ID: 22008827
[TBL] [Abstract][Full Text] [Related]
36. Chimeric cytochromes P450 engineered by domain swapping and random mutagenesis for producing human metabolites of drugs.
Kang JY; Ryu SH; Park SH; Cha GS; Kim DH; Kim KH; Hong AW; Ahn T; Pan JG; Joung YH; Kang HS; Yun CH
Biotechnol Bioeng; 2014 Jul; 111(7):1313-22. PubMed ID: 24474032
[TBL] [Abstract][Full Text] [Related]
37. Catalytically functional flavocytochrome chimeras of P450 BM3 and nitric oxide synthase.
Fuziwara S; Sagami I; Rozhkova E; Craig D; Noble MA; Munro AW; Chapman SK; Shimizu T
J Inorg Biochem; 2002 Sep; 91(4):515-26. PubMed ID: 12237219
[TBL] [Abstract][Full Text] [Related]
38. Artificial Fusions between P450 BM3 and an Alcohol Dehydrogenase for Efficient (+)-Nootkatone Production.
Kokorin A; Urlacher VB
Chembiochem; 2022 Jun; 23(12):e202200065. PubMed ID: 35333425
[TBL] [Abstract][Full Text] [Related]
39. Stabilization of the Reductase Domain in the Catalytically Self-Sufficient Cytochrome P450
Saab-Rincón G; Alwaseem H; Guzmán-Luna V; Olvera L; Fasan R
Chembiochem; 2018 Mar; 19(6):622-632. PubMed ID: 29276819
[TBL] [Abstract][Full Text] [Related]
40. Selective hydroxylation of highly branched fatty acids and their derivatives by CYP102A1 from Bacillus megaterium.
Budde M; Morr M; Schmid RD; Urlacher VB
Chembiochem; 2006 May; 7(5):789-94. PubMed ID: 16566047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
